Literature DB >> 33096041

Evidence synthesis communities in low-income and middle-income countries and the COVID-19 response.

Ruth Stewart1, Amena El-Harakeh2, Sunu Alice Cherian3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 33096041      PMCID: PMC7575272          DOI: 10.1016/S0140-6736(20)32141-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
Evidence synthesis specialists have responded to the COVID-19 pandemic. In line with WHO's global roadmap for COVID-19 research, we are working to summarise the available research to support evidence-informed decision making across all sectors for immediate and anticipated challenges, within the COVID-19 Evidence Network to support Decision-making (COVID-END). COVID-END is an umbrella organisation involving 50 evidence synthesis or evidence support organisations that are working together to promote collaboration and reduce duplication of effort in the conduct and translation of COVID-19-related evidence syntheses. As a network we have accelerated investment to enable infrastructure for evidence synthesis and to promote evidence use. COVID-19 and its related impacts are likely to be felt for many years to come. As the low-income and middle-income country (LMIC) members of a global partnership, we believe that, for global evidence synthesis initiatives to benefit from LMIC expertise and be relevant to LMIC settings, it is important to recognise the conceptual and practical challenges that this pandemic presents to our evidence synthesis organisations. LMIC evidence communities are well placed to support evidence-informed decision making. They include established, locally driven, experienced centres of excellence that are part of technical and regional networks and trusted by decision makers. Our teams and our strong networks are invaluable in promptly getting the best available evidence into the hands of policy makers. However, these achievements are often despite—and not because of—the circumstances in which we work. Many of us work in countries where there are complex challenges. Weak health systems in LMICs are generally struggling to make the necessary responses to the COVID-19 pandemic and the prevalence of comorbidities are putting our populations at increased risk of the direct and indirect consequences of the pandemic. Paramount to poorer and conflict-affected states are the pre-existing, and rapidly worsening, vulnerabilities due to inequalities and inequities, unemployment, hunger, and malnutrition. Violence against women and children, unintended pregnancies, and risks to incarcerated populations are all escalating, as are disruptions to child vaccination programmes. In addition to the mental health strain caused by a pandemic, lockdowns, and resulting social and economic pressures, we are observing fear and stigma associated with COVID-19, quarantine, and isolation. Home evictions linked to job losses, low levels of public health information in some settings, and the presence of migrant workers and refugees have exacerbated xenophobia and social unrest in some LMICs. Older people, migrant workers, refugees, and students have all found themselves vulnerable and inadequately supported. In many countries, these challenges have come on top of entrenched economic, social, and political pressures and present considerable demands on researchers seeking to generate evidence in the COVID-19 response. The demand for evidence to inform decision making, and for effective implementation of such policies, typically outweighs our ability to respond. This situation is compounded by an increased demand for transparency, amid all the mistrust about science that some groups, including certain politicians, bring to the public discourse. As a broad community of evidence synthesis specialists based in LMICs, many of us are experiencing common difficulties arising from limited access to computer hardware and software, restrictions on database access, limited data storage capacity, inadequate data coverage, and low internet bandwidth. Our institutions, like many in poorer settings, are relying on the commitment of individuals, many of whom are using personal computers, living in unfavourable conditions, and working under pressure as they and their families and friends suffer the health, economic, and social impacts of the pandemic. Constrained funds are being repurposed from other projects to enable the increased efforts to generate timely and locally relevant evidence syntheses. In some cases, researchers are working without salaries or with job insecurity. Despite these practical challenges, above and beyond those faced by all researchers producing rapid reviews during this period, our networks continue to generate evidence syntheses to support our governments and strengthen their capacities and resilience. The value of the knowledge translation efforts and rapid response mechanisms to provide timely evidence synthesis is coming into its own, with evidence reaching the highest levels of governments. COVID-19 represents an opportunity to further strengthen and institutionalise evidence-informed policy making across LMICs. We encourage our governments to continue to make good use of, and invest in, the evidence services available to them. Coordination of the research response to COVID-19 is not only crucial to avoid duplication and maximise benefits, but also to ensure that the capacity within LMICs is secured and strengthened for the benefit of us all. Local voices are important for the contextualisation and integration of evidence into decision making. These voices also have a role in shaping the global research agenda for this and future crises. Global initiatives to generate evidence for tackling COVID-19 and for the post-COVID-19 recovery must consider the conceptual and practical challenges faced by research teams in LMICs and recognise the need to strengthen and sustain the voices of LMIC researchers on a global scale. We call for much needed donor support to bolster LMIC evidence synthesis communities and their capacities. We need action from individuals, organisations, governments, and donors to enable and sustain the generation and use of evidence synthesis in LMICs if we are to tackle COVID-19 globally.
  8 in total

1.  Impact of the COVID-19 pandemic on transplantation by income level and cumulative COVID-19 incidence: a multinational survey study.

Authors:  Shaifali Sandal; Allan Massie; Brian Boyarsky; Teresa Po-Yu Chiang; Kednapa Thavorn; Dorry L Segev; Marcelo Cantarovich
Journal:  BMJ Open       Date:  2022-01-12       Impact factor: 2.692

Review 2.  Disruptions in maternal health service use during the COVID-19 pandemic in 2020: experiences from 37 health facilities in low-income and middle-income countries.

Authors:  Zeus Aranda; Thierry Binde; Katherine Tashman; Ananya Tadikonda; Bill Mawindo; Daniel Maweu; Emma Jean Boley; Isaac Mphande; Isata Dumbuya; Mariana Montaño; Mary Clisbee; Mc Geofrey Mvula; Melino Ndayizigiye; Meredith Casella Jean-Baptiste; Prince F Varney; Sarah Anyango; Karen Ann Grépin; Michael R Law; Jean Claude Mugunga; Bethany Hedt-Gauthier; Isabel R Fulcher
Journal:  BMJ Glob Health       Date:  2022-01

3.  COVID-19 in Children with Down Syndrome: Data from the Trisomy 21 Research Society Survey.

Authors:  David Emes; Anke Hüls; Nicole Baumer; Mara Dierssen; Shiela Puri; Lauren Russell; Stephanie L Sherman; Andre Strydom; Stefania Bargagna; Ana Cláudia Brandão; Alberto C S Costa; Patrick T Feany; Brian Allen Chicoine; Sujay Ghosh; Anne-Sophie Rebillat; Giuseppina Sgandurra; Diletta Valentini; Tilman R Rohrer; Johannes Levin; Monica Lakhanpaul
Journal:  J Clin Med       Date:  2021-10-31       Impact factor: 4.241

Review 4.  Data flow within global clinical trials: a scoping review.

Authors:  Kaitlyn Kwok; Neha Sati; Louis Dron; Srinivas Murthy
Journal:  BMJ Glob Health       Date:  2022-04

5.  Challenges to evidence-informed decision-making in the context of pandemics: qualitative study of COVID-19 policy advisor perspectives.

Authors:  Jamie Vickery; Paul Atkinson; Leesa Lin; Olivier Rubin; Ross Upshur; Eng-Kiong Yeoh; Chris Boyer; Nicole A Errett
Journal:  BMJ Glob Health       Date:  2022-04

Review 6.  Lessons learnt: Undertaking rapid reviews on public health and social measures during a global pandemic.

Authors:  Eva A Rehfuess; Jacob B Burns; Lisa M Pfadenhauer; Shari Krishnaratne; Hannah Littlecott; Joerg J Meerpohl; Ani Movsisyan
Journal:  Res Synth Methods       Date:  2022-07-31       Impact factor: 9.308

Review 7.  Paper 4: a review of reporting and disseminating approaches for rapid reviews in health policy and systems research.

Authors:  Shannon E Kelly; Jessie McGowan; Kim Barnhardt; Sharon E Straus
Journal:  Syst Rev       Date:  2022-07-30

8.  A comparison of machine learning algorithms in predicting COVID-19 prognostics.

Authors:  Serpil Ustebay; Abdurrahman Sarmis; Gulsum Kubra Kaya; Mark Sujan
Journal:  Intern Emerg Med       Date:  2022-09-18       Impact factor: 5.472

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.